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Neurocutaneous syndromes represent a vast, largely heterogeneous group of disorders characterized by neurological
and dermatological manifestations, reflecting the common embryonic origin of epidermal and neural tissues. In the
present report, we describe a novel neurocutaneous syndrome characterized by cerebral dysgenesis, neuropathy,
ichthyosis, and keratoderma (CEDNIK syndrome). Using homozygosity mapping in two large families, we localized
the disease gene to 22q11.2 and identified, in all patients, a 1-bp deletion in SNAP29, which codes for a SNARE
protein involved in vesicle fusion. SNAP29 expression was decreased in the skin of the patients, resulting in abnormal
maturation of lamellar granules and, as a consequence, in mislocation of epidermal lipids and proteases. These data
underscore the importance of vesicle trafficking regulatory mechanisms for proper neuroectodermal differentiation.
Introduction
Endocytosis and exocytosis, which are a hallmark of
eukaryotic cells, involve tightly orchestrated mechanisms
ensuring trafficking of numerous molecules and particles
through the formation of membrane carriers, often vesi-
cles (Deitcher 2002). Membrane fusion between vesicles
and target membranes, a critical step in these processes,
is mediated by a large number of the so-called soluble
n-ethylmaleimide sensitive factor attachment protein
(SNAP) receptor (SNARE) proteins (Bonifacino and
Glick 2004). Two classes of SNAREs can be distin-
guished: v-SNAREs, located on vesicular membranes,
and t-SNAREs, located on target membranes. SNAREs
self-assemble into extremely stable four-helix bundles,
composed of two cognate parts, which mediate fusion
between vesicle and target membrane (Ungar and Hugh-
son 2003). SNAP proteins are ubiquitous t-SNARE pro-
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teins that have been shown to promote membrane fusion
in numerous physiological systems (Ungar and Hughson
2003).
To date, very few genetic diseases associated with mu-
tations in genes coding for modulators of vesicle traf-
ficking have been described (Chediak Higashi syndrome
[MIM 214500]; Griscelli syndrome [MIM 214450, MIM
607624]; Hermansky-Pudlak syndrome [MIM 203300];
chylomicron retention disease [MIM 246700]; famil-
ial hemophagocytic lymphohistiocytosis type 4 [MIM
267700]) (Barbosa et al. 1996; Pastural et al. 1997;
Menasche et al. 2000; Huizing and Gahl 2002; Jones
et al. 2003; Gissen et al. 2004; zur Stadt et al. 2005),
and none caused by mutations in genes coding for SNAP
molecules have been reported, possibly owing to a large
degree of functional redundancy among SNARE pro-
teins or to early lethality associated with mutations in
these genes. The present report describes the severe clini-
cal consequences of abnormal expression of a SNAP
protein in humans.
Material and Methods
Patients and Biological Materials
All participants or their legal guardians provided writ-
ten and informed consent according to a protocol ap-
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Table 1
SNAP29 Oligonucleotide Sequences
PROCESS AND EXON
OLIGONUCLEOTIDE SEQUENCE
ANNEALING
TEMPERATURE
(C)Forward Reverse
Genomic DNA amplification:
1 F-GGAGTTCGCGCGACGACCGC R-CAAGAATCTATGCTAGGCAAC 60
2 F-GATGACAGTACCCGTCTCCAG R-GCACTGACGTGGACTGAAAGTC 60
3 F-GAGTTTGGCACAGAGGAGGC R-CTTTGGCTAGCATGGGTGATGC 60
4 F-CATGAGCCTGCGCTGTGCTC R-GACAGTGGCTTACAGAAGCTG 60
5 F-GACAGTGGCTTACAGAAGCTG R-CATCACAATAGAGTGGAAATC 60
dHPLC screening:
1 F-GCGGACAGGCAGCAGTACTTG R-CAAGAATCTATGCTAGGCAAC 60
RT-PCR:
1–5 F-GAGTCCTGGAGCGCACAGAGAAGATG R-CAGCTCATCTAGGTTGCTGTCGATC 60
Quantitative real-time PCR:
3–4 F-GAAGCTATAAGTACAAGTAAAG R-CATCAGTACTCATGGCAGAAC 55
proved by the local Helsinki Committee and by the Com-
mittee for Genetic Studies of the Israeli Ministry of Health.
Blood samples were drawn from all family members,
and DNA was extracted according to standard proce-
dures. Skin-biopsy samples were fixed either in formalde-
hyde for subsequent immunohistochemistry, in Karnow-
ski’s fixative for transmission electron microscopy, or in
paraformaldehyde for immunoelectron microscopy. Fi-
broblast cell cultures were obtained from punch biopsies
from patients or healthy controls after written informed
consent was obtained, and they were maintained in
DMEM supplemented with fetal calf serum 10%.
Transformation of Fibroblasts by SV40 Large T-Antigen
Transfection
Fibroblasts, grown in 10-cm plates, were stably trans-
fected with 10 mg of a plasmid containing the SV40 large
T-antigen coupled to the SV40 early promoter (a gift from
Dr. Danny Canaani, Tel Aviv University, Israel) (Canaani
et al. 1986), by use of 20 ml Lipofectamine 2000 trans-
fection reagent (Invitrogen), according to the manufac-
turer’s instructions. Twelve days later, all colonies in each
plate were trypsinized and split. Transformation was con-
firmed by indirect immunofluorescence. Cells, grown on
cover slips, were fixed with 4% paraformaldehyde and
were incubated first with a monoclonal anti-SV40 large
T-antigen antibody (Gurney et al. 1980) and then with
Cy3-conjugated goat anti-mouse secondary antibodies
(Jackson Immunoresearch Laboratories).
Genotyping
Genomic DNA was PCR amplified using either fluo-
rescently labeled primer pairs (PE Applied Biosystems)
or, for fine mapping, nonlabeled primer pairs. PCR con-
ditions were: 95C for 4 min, followed by 35 cycles of
95C for 30 s, 55C for 30 s, and 72C for 30 s, with a
final extension step of 72C for 5 min. For semiautomated
genotyping, PCR products were separated by PAGE on
an ABI 310 sequencer system, and allele sizes were de-
termined with Genescan 3.1 and Genotyper 2.0 software.
For manual genotyping, amplicons were electrophoresed
on 6% acrylamide gels, followed by silver staining. Multi-
point LOD score analysis was performed with the Super-
Link software (Fishelson and Geiger 2002), under the
assumptions of autosomal recessive inheritance and a mu-
tation frequency of 0.001. Allele frequencies were cal-
culated from analysis of a pool of population-matched
DNA samples.
Sequencing
Genomic DNA was PCR amplified using primer pairs
encompassing all exons and exon-intron boundaries of
the SNAP29 gene (MIM 604202) (table 1). Gel-purified
(QIAquick gel extraction kit, Qiagen) amplicons were
subjected to bidirectional DNA sequencing using the Big-
Dye terminator system on an ABI Prism 3100 sequencer
(PE Applied Biosystems).
To confirm and screen for the 220delG mutation, we
used WAVE analysis (Transgenomic). PCR products were
denatured at 95C for 5 min and were cooled to 65C
down a temperature gradient of 1C/min. Five ml of each
sample were applied to a preheated C18 reversed phase
column based on nonporous polystyrene-divinyl-ben-
zene particles (DNA-Sep Cartridge, Transgenomic). DNA
was eluted within a linear acetonitrile gradient consisting
of buffer A (0.1 M triethylammonium acetate (TEAA)/
buffer B (0.1 M TEAA, 25% acetonitrile) (Transgenom-
ic). The melting profile of the DNA fragment was deter-
mined using Wavemaker 4.2 software and the Stanford
DHPLC Melt program (Bercovich and Beaudet 2003).
RT-PCR
For semiquantitative RT-PCR, total RNA was ex-
tracted from cultured fibroblasts harvested from skin-
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Figure 1 Family trees, genotyping, and clinical spectrum of CEDNIK syndrome. a, Haplotype analysis in two families affected with
CEDNIK syndrome, performed using polymorphic microsatellite markers on 22q11.2. Homozygous disease-associated haplotypes for each
family are marked in gray. b, Severe thickening (keratoderma) of the plantar skin in patient 3. c, Lamellar ichthyosis over the abdominal surface
in patient 14. d, Axial T1 (SE) weighted MR image demonstrating cortical dysplasia and pachygyria with polymicrogyria, as well as typical
absence of corpus callosum, in patient 5.
biopsy samples (RNeasy extraction kit, Qiagen) and was
amplified using the TITAN One Tube RT-PCR kit (Roche
Molecular Biochemicals) and intron-crossing primer pairs
specific for SNAP29 (table 1) or ACTB (MIM 102630),
encoding b-actin (forward, F-CCAAGGCCAACCGCG-
AGAAGATGAC; reverse, R-AGGGTACATGGTGGT-
GCCGCCAGAC). PCR conditions were: 50C for 30
min; 94C for 2 min; 10 cycles of 94C for 30 s, 60C
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for 30 s, and 68C for 90 s; 25 cycles of 94C for 30 s,
60C for 30 s, and 68C for 90 s  5 additional s at
each cycle; and a final extension step at 68C for 7 min.
For quantitative real-time PCR, cDNA was synthe-
sized from 1 mg of total RNA extracted from cultured
fibroblasts using the Reverse-iT first strand synthesis kit
(ABgene) and random hexamers. cDNA PCR amplifica-
tion was performed using the Absolute QPCR SYBR
Green Mix (ABgene) on a Rotor-Gene 3000 multifilter
system (Corbett Research) with primer pairs specific for
SNAP29 (table 1) or ACTB (F-TTGCCGACAGGATG-
CAGAAGGA and R-AGGTGGACAGCGAGGCCAG-
GAT). To ensure the specificity of the reaction condi-
tions, at the end of the individual runs, the melting tem-
perature (Tm) of the amplified products was measured
to confirm its homogeneity. Cycling conditions were as
follows: 95C for 15 min; 95C for 1 s, 55C for 5 s,
and 72C for 5 s for a total of 40 cycles. Each sample
was analyzed in triplicate. For quantification, standard
curves were obtained using serially diluted cDNA am-
plified in the same real-time PCR run. Results were nor-
malized to b-actin mRNA levels. After the quantification
procedure, the products were resolved by 2.5% agarose
gel electrophoresis to confirm that the reaction had am-
plified the correct DNA fragments of known size.
Western Blotting
Cells were homogenized in lysis buffer (10 mM Hepes,
100 mM NaCl, 1 mM MgCl2, 0.5% NP-40, and a pro-
tease-inhibitors mix including 1 mM PMSF and 1 mg/
ml aprotinin and leupeptin [Sigma]). After centrifugation
at 10,000 g for 15 min at 4C, proteins were electropho-
resed through a 10% SDS-PAGE and transferred onto a
nitrocellulose membrane (Schleicher Schuell). After 1 h
blocking with PBS containing 5% skim milk, blots were
interacted with rabbit anti-SNAP29 antibodies (Rotem-
Yehudar et al. 2001). The blots were washed three times
with TBS-Tween (20 mM Tris HCl, 4 mM Tris base, 140
mM NaCl, 1 mM EDTA, 0.1% Tween-20). After incu-
bation with secondary HRP-conjugated goat anti-rabbit
IgG antibodies (Jackson ImmunoResearch) and subse-
quent washings, proteins were detected using the western
blotting Luminol Reagent (Santa Cruz Biotechnology).
To compare the amount of protein in the different sam-
ples, the blots were reprobed with anti-Erk antibodies
(Santa Cruz Biotechnology).
Immunohistochemistry
Formaldehyde-fixed 5-mm paraffin-embedded sections
were treated with 3% H2O2 in methanol for 15 min at
room temperature, were warmed in a microwave oven
in citrate buffer for 15 min at 90C, and were stained
with polyclonal anti-SNAP29 antibodies (Abnova Cor-
poration), anti-keratin 14 antibodies (BioGenex), or
preimmune rabbit antiserum for 1 h at room tempera-
ture. After extensive washings in phosphate-buffered
saline, the antibodies were revealed using the ABC tech-
nique (Zymed), and the slides were counterstained using
hematoxylin.
Electron Microscopy
Transmission electron microscopy (TEM) and immu-
noelectron microscopy (IEM) analyses were performed
as described elsewhere (Ishida-Yamamoto et al. 2005).
For IEM, ultrathin cryosections were incubated with an-
tibodies against glucosylceramides (Glycobiotech), ka-
likrein 5 (KLK5) (Santa Cruz Biotechnology), and KLK7
(Tanimoto et al. 1999).
Results
Clinical Features of CEDNIK Syndrome
We identified two unrelated, consanguineous Arab
Muslim families from northern Israel (fig. 1a), compris-
ing seven affected individuals (four boys and three girls)
displaying a unique constellation of clinical signs. All
patients were born at term after an uneventful gestation,
with normal APGAR scores and birth weight. Roving
eye movements, poor head and trunk control, and failure
to thrive were the presenting symptoms during the first
4 mo of life. All patients had progressive microcephaly
and facial dysmorphism including elongated faces, anti-
mongolian eye slant, slight hypertelorism, and flat broad
nasal root. Palmoplantar keratoderma (fig. 1b) and ich-
thyosis (fig. 1c) appeared between 5 and 11 mo of age,
with progressive worsening during the 2nd year of life.
By the age of 8–15 mo, psychomotor retardation became
apparent as major developmental milestones, like un-
aided sitting and walking, were not attained. Tendon
reflexes could not be elicited, and peripheral nerve con-
duction studies performed in three patients demon-
strated low-amplitude responses. Muscle biopsies per-
formed in two patients disclosed neurogenic atrophy and
normal activity of the mitochondrial respiratory chain
complexes. Ophthalmologic evaluation revealed hypo-
plastic optic disk; electrophysiological studies were sug-
gestive of reduced conductance from peripheral retina
and macular atrophy. Mild sensorineural deafness was
demonstrated in three patients studied. Brain MRI per-
formed on four patients showed various degrees of cor-
pus callosum abnormalities and cortical dysplasia, with
pachygyria and polimicrogyria (fig. 1d). Three male pa-
tients died of aspiration pneumonia between 5 and 12
years of age. To date, four patients, aged 5–13 years,
are alive, with features including severe psychomotor
retardation, ichthyosis, and palmoplantar keratoderma.
The results of routine laboratory studies, plasma and
urinary amino acids, urinary organic acids, serum lac-
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Figure 2 Mutation analysis and gene expression. a, Sequence analysis revealed a homozygous G deletion at SNAP29 cDNA position 220
in all affected individuals of both families (upper panel). All obligatory carriers were shown to carry the mutation in a heterozygous state
(middle panel). The wild-type sequence is given for comparison (lower panel). b, The corresponding dHPLC tracings obtained by running PCR
samples unmixed and mixed with control DNA are depicted. c, Expression of SNAP29 and ACTB, coding for b-actin, assessed using RT-PCR
in fibroblasts harvested from a patient (P) and from a healthy control individual (C). Note the lower amounts of the SNAP29 RT-PCR products
in the patient relative to the control. d, Quantitative real-time PCR analysis for gene expression of SNAP29 in fibroblasts obtained from control
and patient skin. Expression levels are expressed as absolute values normalized relative to b-actin RNA levels.
tate, copper, and ceruloplasmin were within normal lim-
its. Karyotype was normal. Using a battery of enzymatic
and biochemical assays, as well as lipid staining in leuko-
cytes and hair microscopy, we excluded a large number
of syndromes with closely related clinical manifestations,
including Sjogren Larsson syndrome (MIM 270200),
peroxisomal disorders, congenital disorders of N- and
O-glycosylation, Chanarin-Dorfman disease (MIM
275630), trichothiodystrophy (MIM 601675), Gaucher
disease (MIM 230900), steroid sulfatase (MIM 308100),
and multiple sulfatase deficiency (MIM 272200).
Mapping of CEDNIK Syndrome
Given the apparent rarity of the syndrome and the
fact that the two affected families were consanguineous
and lived a few miles from one another, we assumed the
existence of a single homozygous causative mutation.
We therefore established the genotypes at 332 micro-
satellite loci of five patients from whom DNA was avail-
able and scrutinized our results for regions of homo-
zygosity. A homozygous haplotype spanning 4 Mb on
22q11.2 was found to be shared by all affected individ-
uals and to be absent or carried in a heterozygous state
by other healthy family members (not shown). We sub-
sequently genotyped all family members, using 13 mark-
ers saturating the putative disease interval. Multipoint
LOD score analysis generated a maximum score of 4.85
at marker D22S446. Haplotype analysis identified a criti-
cal recombination event in individual 8 and loss of ho-
mozygosity in individual 14, at markers D22S308 and
D22S873, respectively, thereby establishing the telo-
meric and centromeric boundaries of the disease-asso-
ciated interval.
SNAP29 Mutation Analysis
The CEDNIK-associated interval, spanning ∼2 Mb,
was found to harbor 84 genes, among which SNAP29,
coding for a SNARE protein involved in intracellular
vesicle fusion, was chosen as our prime candidate be-
cause it modulates critical physiological processes in the
central and peripheral nervous system (Su et al. 2001).
Sequencing of this gene revealed in all patients a G
deletion at cDNA position 220 (starting from ATG) (fig.
2a), which was predicted to result in frameshift and in
the synthesis of a significantly truncated protein due to
premature termination of translation 28 amino acids
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Figure 3 SNAP29 protein expression. Skin biopsy sections obtained from a control individual (a, c, and e) and a patient with CEDNIK
(b, d, and f) were stained with antibodies directed against SNAP29 (a and b) and keratin 14 (c and d) and with preimmune rabbit antiserum
(e and f). Note the very thickened stratum corneum (hyperkeratosis), marked by an asterisk (*). Cytoplasmic staining for SNAP29 shows positive
results in keratinocytes as well as dermal fibroblasts in control skin, but not in the skin of the patient (original magnification #400). g, To
confirm the immunostaining results, protein was extracted from transformed fibroblast cell cultures established from patient skin (patients 4
and 6), from control transformed skin fibroblasts (SV80), and from HeLa cells. Cell lysates containing 80 mg of protein were electrophoresed
through 10% SDS-PAGE, and the corresponding immunoblot was reacted with anti-SNAP29 antibodies. Detection was performed with HRP-
conjugated goat anti-rabbit antibodies. Membranes were reblotted with anti-Erk antibodies to control for protein loading.
downstream of the mutation. Using dHPLC hetero-
duplex analysis, we confirmed segregation of the mu-
tation in the two families (fig. 2b) and excluded the
mutation from a panel of 200 population-matched con-
trol chromosomes.
SNAP29 Expression in Skin of Patients with CEDNIK
Syndrome
The 220delG mutation in SNAP29 gene was found to
be associated with decreased levels of SNAP29 tran-
scripts (fig. 2c), possibly reflecting nonsense-mediated
mRNA decay. Using quantitative RT-PCR, we found that
SNAP29 RNA expression was decreased 99-fold in pa-
tient fibroblasts relative to control fibroblasts (fig. 2d).
To assess the consequences of the mutation at the protein
level, we stained skin-biopsy samples obtained from pa-
tients and control individuals with anti-recombinant
SNAP29 antiserum. SNAP29 was found to be expressed
by virtually all cells in the normal epidermis and dermis
(fig. 3a). In contrast, SNAP29 expression was markedly
reduced in the skin of affected individuals (fig. 3b). This
decrease in SNAP29 expression was specific, since the
expression of unrelated proteins such as keratin 14 was
unchanged (fig. 3c and 3d) and staining with preimmune
rabbit serum showed negative results (fig. 3e and 3f).
We then confirmed these results using western blot an-
alysis of protein extracted from SV40-transformed nor-
mal fibroblasts and SV40-transformed fibroblasts grown
from skin-biopsy samples obtained from two patients
(fig. 3g). Similar results were obtained using primary
fibroblast cell cultures (not shown). Thus, 220delG mu-
tation results in SNAP29 deficiency in the skin of pa-
tients with CEDNIK syndrome.
Ultrastructural Consequences of SNAP29 Deficiency
in CEDNIK Syndrome
Lamellar granules are abundant organelles typically
found in the upper epidermal layers and responsible for
delivering to the stratum corneum lipids, proteases, and
their inhibitors during the process of epidermal barrier
formation (Fartasch 2004). A large body of evidence sup-
ports the concept that lamellar granules originate from
the Golgi complex (Ishida-Yamamoto et al. 2005). In
parallel, a number of studies have shown that SNAP29,
in contrast with other SNAP proteins (Gonelle-Gispert
et al. 2000; Feng et al. 2002), is prominently found in
intracellular membrane structures (Steegmaier et al. 1998;
Ugur and Jones 2000; Hohenstein et al. 2001) and have
suggested a specific role for SNAP29 in mediating Golgi
trafficking (Wong et al. 1999). To assess the possibility
that SNAP29 deficiency interferes with epidermal gran-
ule maturation, we examined skin-biopsy samples ob-
tained from a CEDNIK patient by TEM. The most strik-
ing ultrastructural abnormality in the patient epidermis
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Figure 4 Transmission electron micrograph of a skin-biopsy sample obtained from a patient (a, b, e, and f) and from a healthy control
individual (c and d). Panels b, d, and f show higher-magnification views of the areas marked in panels a, c, and e, respectively. In addition to
normal appearing lamellar granules with (black arrows) or without (black arrowheads) lamellar internal structures, numerous empty vesicles
(white arrowheads) are seen in the patient epidermis (b) but not in the control skin (d). e and f, The extracellular spaces between the most
superficial granular cells and the cornified cells in the patient skin contain secreted lamellar granule contents (white arrows in panel f). In
addition, countless abnormal vesicles are observed in the lower stratum corneum (white arrowheads). The letters C, G, and S identify the
epidermal cornified, granular, and spinous cell layers, respectively.
was the presence of countless clear vesicles in the spinous
and granular epidermal layers (fig. 4a and 4b) that were
not found in control epidermis (fig. 4c and 4d). Vesicles
of various sizes and contents were also present, abnor-
mally, in the lower layers of the significantly thickened
stratum corneum in patient skin (fig. 4e and 4f) but not
in normal skin (not shown). It is of note that normal-
looking lamellar granules, loaded with lipid molecules,
were also seen (fig. 4b), and they were released into the
extracellular space between the superficial granular and
cornified layers (fig. 4e and 4f). We did not observe any
additional abnormality in other epidermal structures.
Epidermal differentiation is critically dependent on
proper spatial deposition of lipids and proteolytic en-
zymes, which contribute to the formation of the skin
barrier and mediate desquamation, respectively (Ishida-
Yamamoto et al. 2005). Because the transfer of these
molecules to the stratum corneum is, in turn, dependent
on correct formation of lamellar granules, and because
lamellar granule maturation was found to be abnormal
in CEDNIK syndrome (fig. 4), we assessed the distri-
bution of glucosylceramides in patient skin, using IEM.
Glucosylceramides are precursor molecules for cerami-
des, the most abundant intracorneal lipids, and are nor-
mally secreted between granular and cornified epidermal
cells (Ishida-Yamamoto et al. 2005) (fig. 5, left panel).
In the skin of our patients, considerable amounts of
glucosylceramides were retained, abnormally, within the
cells of lower stratum corneum (fig. 5, middle panel) and
numerous vesicles with positive glucosylceramide label-
ing were seen in the lower cornified layer (fig. 5, right
panel), indicating that lamellar granules are not correctly
secreted in the skin of patients with CEDNIK syndrome.
Abnormal vesicles in the cornified cells were also found
to contain KLK5 and KLK7, two proteases of major
importance for normal desquamation (Caubet et al. 2004)
(not shown).
Discussion
In the present study, we describe a novel neurocutaneous
disease, termed “CEDNIK syndrome,” characterized by
severe developmental abnormalities of the nervous sys-
tem as well as aberrant differentiation of the epidermis.
We show that this disorder results from decreased ex-
pression of SNAP29, a SNARE protein involved in vesi-
cle fusion. Although neural tissues were not available
for examination, ultrastructural features of the syn-
drome in the skin of patients, including the presence of
abnormal vesicles in the granular and lower cornified
cell layers of the epidermis, are consonant with deranged
function of SNARE-mediated vesicle transport/fusion.
Interestingly, abnormal vesicles were also observed in
dermal fibroblasts (not shown), suggesting a generalized
defect in vesicle trafficking in patient tissues. Although,
to our knowledge, similar ultrastructural features have
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Figure 5 Immunoelectron microscopy of skin-biopsy samples obtained from two CEDNIK patients and a control individual with antibodies
directed against glucosylceramides (GlcCer). Glucosylceramides appear as black dots. In the control samples, glucosylceramides are found in
lamellar granules, and they are secreted between the epidermal granular cells (G) and cornified cells (C) (left panel). By contrast, in patient
skin, only a small proportion of glucosylceramide-positive granules is secreted into the extracellular spaces (ECS) between the granular and
cornified cells, a large amount of glucosylceramides is found in the lower cornified cells (middle panel), which are shown to retain a very large
number of glucosylceramide-positive vesicles (white arrowheads in right panel). The black arrow marks the cornified cell envelope (CE).
never previously been described in a human disease, they
bear striking resemblance to the phenotype observed in
mutant yeasts with abnormal SNARE complex function
causing defective fusion of transport vesicles with the
Golgi apparatus (Bonifacino and Glick 2004). As men-
tioned above, SNAP29 has been shown to play an im-
portant role in Golgi trafficking (Wong et al. 1999).
Abnormal SNAP29-mediated vesicle fusion may ex-
plain the major clinical features characteristic of CED-
NIK syndrome. Indeed, numerous studies have under-
scored the importance of the SNARE machinery during
brain development, axonal growth, synaptogenesis, and
neurotransmission (Hepp and Langley 2001; Chen and
Olson 2005). SNARE proteins have also been shown to
play an important role in the development of the retina
(West-Greenlee et al. 1998). The prominent ophthal-
mologic signs observed in patients with CEDNIK syn-
drome—including roving eye movements during the first
months of life (or even at birth, in one patient), early
macular atrophy, and reduced conductance from periph-
eral retina demonstrated by electrophysiological stud-
ies—together suggest a pivotal function for SNAP29 in
the development of the visual system. SNAP29 regulates
neurotransmitter release by slowing the recycling of the
fusion machinery and down-regulating synaptic vesicle
turnover (Su et al. 2001; Pan et al., in press). The process
of synaptic vesicle recycling, including SNARE complex
formation and dissociation, is essential for ongoing syn-
aptic transmission (Sudhof 2004). SNAP29 deficiency
may therefore explain the development of the severe
neuropathy displayed by patients with CEDNIK syn-
drome. Moreover, the skin findings in CEDNIK syn-
drome are likely to result from abnormal lamellar
granule maturation and secretion (figs. 4 and 5). Al-
though in normal skin, lamellar granules release lipids
and proteases beneath the stratum corneum, reinforc-
ing the epidermal barrier and mediating desmosome
dissolution during desquamation, respectively, in CED-
NIK syndrome, glucosylceramide and kallikrein-con-
taining granules are aberrantly retained in the stratum
corneum, leading to abnormal barrier formation and
retention hyperkeratosis (fig. 6).
CEDNIK syndrome includes a number of features
overlapping with clinical characteristics of other genetic
diseases, which is suggestive of intersecting pathophy-
siologies. For example, lamellar body degeneration has
been observed in type II pneumocytes in Hermansky-
Pudlak syndrome, another autosomal recessive disorder
associated with impaired vesicle trafficking (Nakatani
et al. 2000). Also, the occurrence of neurocutaneous
signs associated with abnormal distribution of gluco-
sylceramides in the skin of patients with CEDNIK syn-
drome is reminiscent of the clinical phenotype resulting
from decreased hydrolysis of glucosylceramide to cera-
mide in type II Gaucher disease (Holleran et al. 1994),
where severe ichthyosis can be observed along with neu-
rological deficits.
In conclusion, we have described a novel human ge-
netic disease, caused by decreased expression of SNAP29
and resulting in abnormal vesicle maturation and se-
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Figure 6 Pathogenesis of CEDNIK syndrome. a, Formation of the epidermal barrier occurs at the end of a complex differentiation process
during which keratinocytes, derived from the proliferating basal cell layer, sequentially transform into spinous cells, granular cells, and cornified
cells as they migrate outwards throughout the epidermis. b, The epidermal barrier is composed of the cornified cell envelope (CE), a protein
scaffold, which replaces the plasma membrane; intracellular cross-linked and polymerized keratin filament bundles; and extracellular lipid layers.
Lipids, such as glucosylceramides (GlcCer), are normally secreted from lamellar granules present in granular cells into the extracellular space
(ECS) between the granular and the cornified cell layers. Lamellar granules also secrete proteases, such as KLK5 and KLK7, which dissolve
desmosomal plates in the upper cornified cell layers, thereby enabling cells to separate one from the other, a process known as “desquamation.”
In CEDNIK syndrome, lamellar granules are retained within the cornified cell layer, and the diminished secretion of lipids and proteases in the
ECS, causes impaired barrier formation and decreased desquamation, respectively, which explains the increased thickness of the outer epidermal
layers in patients.
cretion. These data underscore the importance of the
SNARE complex in general and of SNAP29 in particu-
lar for normal neuroectodermal differentiation.
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